Compound ID | 550
Class: Fluoroquinolone
Spectrum of activity: | Gram-positive & Gram-negative |
Details of activity: | Was in development for veterinary medicine and is potent against both Gram positive and negative |
Institute where first reported: | The Upjohn Company (Pfizer, USA) |
Year first mentioned: | 1995 |
Highest developmental phase: | Preclinical |
Development status: | Inactive |
Chemical structure(s): | |
Canonical SMILES: | C[C@@H]([C@@H]1CCN(C1)C2=C(C3=C(C=C2F)C(=O)C(=CN3C4CC4)C(=O)O)OC)NC |
Isomeric SMILES: | C[C@@H]([C@@H]1CCN(C1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F)NC |
InChI: | InChI=1S/C21H26FN3O4/c1-11(23-2)12-6-7-24(9-12)18-16(22)8-14-17(20(18)29-3)25(13-4-5-13)10-15(19(14)26)21(27)28/h8,10-13,23H,4-7,9H2,1-3H3,(H,27,28)/t11-,12+/m0/s1 |
InChI Key: | SUQUWONDIBHQOZ-NWDGAFQWSA-N |
Structure link: | https://pubchem.ncbi.nlm.nih.gov/compound/71455 |
External links: | |
Guide to Pharmacology: | premafloxacin |
Main Source: | https://www.sciencedirect.com/science/article/pii/S0022354915504449?via%3Dihub |
Citation: | http://jac.oxfordjournals.org/content/38/4/742.full.pdf |